Insufficient Evidence to Support Medical Cannabis for Insomnia Treatment

A new Cochrane systematic review concludes that current evidence is too limited and uncertain to determine whether medical cannabis effectively improves sleep quality or daytime functioning in people with insomnia. The review highlights the lack of robust clinical trials comparing cannabis to standard treatments or placebos. This finding is significant for patients considering cannabis as an alternative therapy, as it emphasizes the need for more rigorous research before medical recommendations can be made. Healthcare providers should continue relying on evidence-based insomnia treatments while researchers work to establish cannabis's true efficacy and safety profile.